Martin Schrappe

20PUBLICATIONS
206CO-AUTHORS
Haematological tumoursInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|May 27, 2026
Safety of Telemedicine Follow-Up Visits in Children With Cancer Undergoing Intensive Chemotherapy: Results From the Randomized KULT-SH Trial.

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Aug 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.

Gudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky

|Mar 25, 2025
NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation.

Michaela Kotrová, Constantin Proske, Nikos Darzentas

Pageof 4

Frequent Collaborators

9 joint publications

Andishe Attarbaschi

8 joint publications

Jan Stary

7 joint publications

Sarah Elitzur

6 joint publications

Martin Zimmermann